Relmada Therapeutics, Inc. RLMD Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s software and technology licenses, net?
- Relmada Therapeutics, Inc. (RLMD) reported software and technology licenses, net of $19.5K in Q1 2026.
- How has Relmada Therapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Relmada Therapeutics, Inc.'s software and technology licenses, net decreased by 11.3% year-over-year, from $21.98K to $19.5K.
- What is the long-term trend for Relmada Therapeutics, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s software and technology licenses, net has grown at a -4.8% compound annual growth rate (CAGR), from $25K to $19.5K.